Why is the Telix Pharmaceuticals share price frozen today?

Telix Pharmaceuticals shares won't be moving today.

| More on:
A person wrapped in warm clothing with head, eyes and face covered by a hat, glasses and a scarf is coated in a layer of snow and ice. representing Strike Energy's trading halt today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Up 63% so far in 2024, the Telix Pharmaceuticals Ltd (ASX: TLX) share price isn't going anywhere today.

Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed yesterday trading for $16.46 apiece. Which is where they're likely to stay until Monday.

This morning, Telix Pharmaceuticals shares were placed on trading halt at the company's request "pending it releasing an announcement".

Shares are expected to remain frozen until Monday.

While the release didn't specify, the announcement most likely will provide further details on the ASX biotech stock's proposed initial public offering (IPO) on Wall Street.

Last Thursday, 6 June, Telix confirmed its intent to list American Depositary Shares (ADSs) on the tech-heavy Nasdaq. Each ADS will represent one ordinary share in Telix. The company is targeting US$200 million in gross proceeds from the offering.

Commenting on the Nasdaq IPO process back in late May, Telix Pharmaceuticals chair Kevin McCann said, "It enables Telix to better access the deep pool of specialist investors focused on biotechnology and radiopharmaceuticals in the US."

As for the longer-term impact on the Telix Pharmaceuticals share price, McCann said that the increased visibility the Nasdaq listing would provide "will drive long-term value creation for shareholders".

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Guess which ASX 200 stock just jumped 9% on big news

Let's find out what is getting investors excited today.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

What are Cochlear shares worth according to Macquarie?

Let's see what the broker is saying about this blue chip.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

When will CSL shares finally catch a break?

Here's where analysts think the biotech stock is heading next.

Read more »

An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands as he looks at the CBA share price movement today
Healthcare Shares

JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?

Can this ASX 200 juggernaut go higher?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why this top broker expects CSL shares to surge 26%

A leading broker foresees a big rebound ahead for CSL shares. But why?

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

Guess which ASX All Ords stock is jumping on big US news

This small cap is catching the eye on Thursday. But why?

Read more »

three excited doctors with hands in the air
Healthcare Shares

Two ASX healthcare shares that could be set to double

This broker has buy recommendations on these two shares. 

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Telix shares jump 7% on big US news

Let's see what is getting investors excited on Wednesday.

Read more »